BIOENVISION INC
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Signs
● 1 severe● 0 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Sep 28, 2005
- NT 10-Qmissed a reporting deadline ↗May 16, 2005
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2001
- NT 10-Kmissed a reporting deadline ↗Sep 28, 2001
- NT 10-Qmissed a reporting deadline ↗May 15, 2001
- NT 10-Qmissed a reporting deadline ↗Feb 15, 2001
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
FDA-approved drugs
openFDA · most recent- MODRASTANEDec 31, 1984
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Perseus Soros Biopharmaceutical Fund Lp10% owner | Jul 10, 2007 | J | 3.4M | $5.60 |
| Wood Christopher BOfficer — CEO and Chairman | Jul 10, 2007 | U | 1.7M | $5.60 |
| Sterling RobertOfficer — VP-Product Development | Jul 10, 2007 | U | 15,225 | $5.60 |
| Nelson Thomas ScottDirector | Jul 10, 2007 | U | 79,955 | $5.60 |
| Luci David POfficer — EVP & General Counsel | Jul 10, 2007 | U | 310,154 | $5.60 |
| Genzyme Corp10% owner | Jul 10, 2007 | Buy | 8.7M | $5.60 |
| Sco Capital Partners Llc10% owner | May 1, 2007 | Option exercise | 688,333 | $1.50 |
| Perseus Soros Biopharmaceutical Fund Lp10% owner | May 2, 2007 | Option exercise | 3.0M | $2.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Other material eventOct 11, 2007
- Other material eventOct 10, 2007
- Results of operationsSep 12, 2007
- Other material eventAug 31, 2007
- Other material eventAug 16, 2007
- Director / officer changeJul 30, 2007
- Other material eventJul 27, 2007
- Director / officer changeJul 16, 2007
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.